- Posted Monday October 1, 2012
Key to the Cure' charity-shopping weekend focused on women
October 1, 2012
Join Academy Award-winning actress Penélope Cruz, 2012
Entertainment Industry Foundation's Women's Cancer Research Fund
ambassador, by attending Saks Fifth Avenue's 2012 Key to the
Oct. 18-21, during Key to the Cure's Friends & Family Shopping Weekend, the Saks Fifth Avenue store at Biltmore Fashion Park, 24th Street and Camelback Road, will donate 2 percent of sales to support breast and ovarian cancer research at the Translational Genomics Research Institute (TGen).
The big event that weekend is the Key to the Cure kick-off celebration, from 8:30-11 a.m. Oct. 19, featuring a fashion show, raffle, food, drinks, and live entertainment. Tickets for the kick-off celebration are $125, and available through TGen at www.helptgen.org or at 602-343-8572.
Fashion show guests will get to meet designer David Meister, whose designs are synonymous with sophisticated women's wear. His red-carpet devotees include Hollywood actresses Diane Lane, Katherine Heigl, Queen Latifah, Tina Fey, and Drew Barrymore.
Starting today, Oct. 1, Saks stores, Saks' OFF 5TH stores, and saks.com will offer a limited edition Key To The Cure T-shirt designed by Carolina Herrera. The $35 purchase price of each shirt sold will be donated to local charity partners, including TGen.
National Awareness, Local Impact
In support of Key to the Cure, Ms. Cruz will appear in a national public service announcement (PSA) wearing the Key to the Cure T-shirt. She was the first Spanish actress to win an Academy Award - an Oscar for Best Supporting Actress in 2008 for her role in Vicky Cristina Barcelona. Her Key To The Cure PSA will appear in September and October editions of major fashion and lifestyle magazines.
Saks Fifth Avenue initiated its charity-shopping weekend in 1999. Since then, the company has donated $34 million to women's cancer research and treatment organizations throughout the U.S., including: The Breast Cancer Research Foundation; EIF's Women's Cancer Research Fund; Cleveland Clinic; Boston's Dana-Farber Cancer Institute; and the Nevada Cancer Institute.
Breast cancer remains the most common type of cancer among women in the U.S., with an incidence rate nearly twice that of lung cancer. Though treatments have improved, nearly 40,000 American women will die this year from breast cancer.
TGen is dedicated to finding new and better cancer treatments, focusing on personalized medicine that targets each cancer's genetic vulnerabilities while minimizing harmful side effects.
TGen's Breast and Ovarian Cancer Research Unit seeks to unravel the complex nature of cancer, aiming for new methods of prevention, early diagnosis, and groundbreaking therapeutics. Data generated through TGen's leading-edge genomic research can help oncologists pinpoint the potential causes of individual tumors, and shed light on the best treatments for each patient.
Learn more about TGen's research, and how you can help, by visiting www.helptgen.org.
See a video supporting Key to the Cure at: youtube.com/watch?v=BvYabhv6cTY.
About Saks Fifth Avenue
Saks Fifth Avenue, one of the world's preeminent specialty retailers, is renowned for its superlative American and international designer collections, its expertly edited assortment of handbags, shoes, jewelry, cosmetics and gifts, and the first-rate fashion expertise and exemplary client service of its Associates. Today, Saks operates 45 full-line stores in 21 states, 2 licensed stores in the Middle East and 2 licensed stores in Mexico City, 61 Saks Fifth Avenue OFF 5TH stores and saks.com, the company's online store.
Saks Fifth Avenue is proud to be named a J.D. Power and Associates 2012 Customer Service Champion and is only one of 50 U.S. companies so named.
Director of Marketing
602-955-8000, ext. 5202
The Translational Genomics Research Institute (TGen) is a Phoenix-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.
TGen Senior Science Writer